These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 292598)

  • 1. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
    Sonneveld P; Holcenberg JS; van Bekkum DW
    Eur J Cancer (1965); 1979 Aug; 15(8):1061-3. PubMed ID: 292598
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.
    Schmid FA; Roberts J
    Cancer Chemother Rep; 1974; 58(6):829-40. PubMed ID: 4447925
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical influence of an enzyme-elevating virus upon long-term remissions of mouse leukemia following asparaginase therapy.
    Riley V; Spackman DH; Fitzmaurice MA
    Recent Results Cancer Res; 1970; 33():81-101. PubMed ID: 4949171
    [No Abstract]   [Full Text] [Related]  

  • 5. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
    Warrell RP; Chou TC; Gordon C; Tan C; Roberts J; Sternberg SS; Philips FS; Young CW
    Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase.
    Wu MC; Arimura GK; Holcenberg JS; Yunis AA
    In Vitro; 1982 Sep; 18(9):750-4. PubMed ID: 7173949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial glutaminase in treatment of acute leukaemia.
    Spiers AS; Wade HE
    Br Med J; 1976 May; 1(6021):1317-9. PubMed ID: 773514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.
    Holcenberg JS; Borella LD; Camitta BM; Ring BJ
    Cancer Res; 1979 Aug; 39(8):3145-51. PubMed ID: 455299
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
    Adamson RH; Fabro S
    Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologic and physical properties of succinylated and glycosylated Acinetobacter glutaminase-asparaginase.
    Holcenberg JS; Schmer G; Teller DC
    J Biol Chem; 1975 Jun; 250(11):4165-70. PubMed ID: 1126947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemotherapy of human and animal acute leukemia.
    Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
    Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
    [No Abstract]   [Full Text] [Related]  

  • 15. BN rat myeloid leukemia transferred to the (LEW x BN)F1 rat.
    Vaughn WP; Burke PJ; Jung J
    J Natl Cancer Inst; 1978 Sep; 61(3):927-9. PubMed ID: 308545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 18. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electron microscopic observations on the effect of L-asparaginase at transplanted leukemias of the mouse].
    Voigt WH; Grundmann E; Bierling R
    Beitr Pathol Anat; 1970; 140(2):237-55. PubMed ID: 5418958
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
    Martens AC; de Groot CJ; Hagenbeek A
    Eur J Cancer; 1991; 27(2):161-6. PubMed ID: 1827281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.